Entrada Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $1.1M | 163k | 6.72 |
| 2024-12-31 | $1.4M | 82k | 17.29 |
| 2024-09-30 | $1.5M | 93k | 15.99 |
| 2024-06-30 | $699k | 49k | 14.25 |
| 2024-03-31 | $1.5M | 108k | 14.17 |
| 2023-12-31 | $744k | 49k | 15.09 |
| 2023-09-30 | $331k | 21k | 15.80 |
| 2023-06-30 | $452k | 30k | 15.10 |
| 2022-12-31 | $337k | 25k | 13.52 |
| 2022-06-30 | $284k | 21k | 13.42 |
| 2022-03-31 | $77k | 8.4k | 9.20 |